Johnson & Johnson

Based in New Brunswick, Johnson & Johnson is widely regarded as one of USA's flagship pharmaceuticals operators. Its scale — about 132k people, around $85B in turnover — translates into genuine strategic weight across North America.

Management's emphasis on operational discipline — tight working capital, focused capex, clearer ESG roadmaps — is increasingly visible in margin trajectory.

“Johnson & Johnson is, in its category, exactly the kind of compounding regional champion the next decade of capital allocation will reward.”

Governance upgrades and a more transparent disclosure cadence are gradually narrowing the historical valuation gap with global peers.